VRSN
53
-2
KEY
51
-3
RF
51
-2
MTCH
44
-4
PEP
47
-3
ED
53
4
SWN
77
4
L
55
-4
TXN
50
-3
STT
51
-5
PPL
65
6
PEG
76
5
BMY
56
3
PLD
51
-5
IVZ
50
-3
MLM
53
-5
KSS
39
6
USB
44
-3
MDT
53
-2
LB
38
-7
VRSN
53
-2
KEY
51
-3
RF
51
-2
MTCH
44
-4
PEP
47
-3
ED
53
4
SWN
77
4
L
55
-4
TXN
50
-3
STT
51
-5
PPL
65
6
PEG
76
5
BMY
56
3
PLD
51
-5
IVZ
50
-3
MLM
53
-5
KSS
39
6
USB
44
-3
MDT
53
-2
LB
38
-7
Financhill
Back

Lithium Royalty Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
7

LIRC.TO
Lithium Royalty

Last Price:
5.91
Seasonality Move:
-24.22%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
7
Lithium Royalty (LIRC.TO) is a Sell

Is Lithium Royalty a Buy, Sell or Hold?

  • The current Lithium Royalty [LIRC.TO] share price is $5.91. The Score for LIRC.TO is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
  • LIRC.TO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LIRC.TO Stock Price Chart

What is Lithium Royalty's stock price today?

  • The Lithium Royalty share price today is $5.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIRC.TO is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

LIRC.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 34 Sell
Chaikin Money Flow: -1700 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.94 - 6.36) Sell
Bollinger Bands (100): (6.25 - 7.09) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

LIRC.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.96 Sell
20-day SMA: 6.07 Sell
50-day SMA: 6.49 Sell
200-day SMA: 7.19 Sell
8-day EMA: 5.95 Sell
20-day EMA: 6.09 Sell
50-day EMA: 6.36 Sell
200-day EMA: 7.7 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Lithium Royalty Earnings Growth & LIRC.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.06 per share, an increase this year of $0.06 per share, and an increase next year of $0.15 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Lithium Royalty Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):